Cyclobenzaprine Hydrochloride
- Product NDC
- 0591-3330
- 11-digit product format
- 005913330
- Labeler code
- 0591
- Product ID
- 0591-3330_015c8193-79db-4eee-9a44-883138b5ee5a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA071611
- Marketing category
- ANDA
- Marketing start
- 2006-02-03
- Marketing end
- 2023-08-31
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-3330-01 | 00591333001 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3330-01) | 2006-02-03 | 2023-08-31 | No | No | Current |